Sai Life
Diagnostics & Research · SAILIFE
Mid CapHealthcareHigh Growth
Krishna Kanumuri
Managing Director and CEO · Pragmatic
Company DNA
Innovation-Led
About
Sai Life is a Mid Cap company in the Healthcare sector, listed on NSE as SAILIFE. With a market cap of ₹21K Cr and revenue of ₹2K Cr, it is currently in the High Growth phase. Known for its Innovation-Led culture and Disruptor approach to innovation, the company operates at a Startup-Speed pace. Focuses on R&D and pharmaceutical research, requiring a culture that encourages specialized technical expertise and scientific experimentation. Its strategic mandate: Scaling in the CDMO space requires a bold leader capable of capturing global market share through rigorous quality standards and capacity scaling.
FAQ
What kind of company is Sai Life?
Sai Life is a Mid Cap Healthcare company (SAILIFE) in the High Growth phase with a market cap of ₹21K Cr. It is classified as Innovation-Led in culture.
What is Sai Life's culture and work environment like?
Sai Life has a Innovation-Led culture with Disruptor innovation DNA and a Startup-Speed pace of execution. Employee brand: Learning Ground. Customer relationship style: B2B-Enterprise. Focuses on R&D and pharmaceutical research, requiring a culture that encourages specialized technical expertise and scientific experimentation.
Who leads Sai Life?
Sai Life is led by Krishna Kanumuri (Managing Director and CEO), a Pragmatic leader with 31 years of experience.
What are Sai Life's financials?
Sai Life reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 24.1%. Operating margin: 16.5%. Market cap: ₹21K Cr.
Culture & Strategy
CultureInnovation-Led
InnovationDisruptor
PaceStartup-Speed
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleHigh Growth
Focuses on R&D and pharmaceutical research, requiring a culture that encourages specialized technical expertise and scientific experimentation.
Mandate
Scaling in the CDMO space requires a bold leader capable of capturing global market share through rigorous quality standards and capacity scaling.
Scaling in the CDMO space requires a bold leader capable of capturing global market share through rigorous quality standards and capacity scaling.
Financials
Revenue FY25₹2K Cr
PAT FY25₹170 Cr
Rev CAGR 5Y24.1%
OPM16.5%
NPM10.2%
ROE8%
ROCE11.3%
P/E60.2
Fwd P/E48.2
P/B8.8
D/E18.4
Mkt Cap₹21K Cr
Promoter38.1%
Institutional41.4%
Similar Culture
Could You Lead Sai Life?
Take the Genome Benchmark →